Ali Behbahani - Net Worth and Insider Trading

Over the past 18 months, Ali Behbahani made 1 insider transaction in Metacrine Inc (MTCR) with a net sale of 497,270. Other recent insider transactions involving Metacrine Inc (MTCR) include a net purchase of 2,510,570 shares made by Braden Michael Leonard , a net sale of 425,353 shares made by Preston Klassen , and a net sale of 615,702 shares made by Venbio Global Strategic Fund, L.p. .

In summary, during the past 3 months, insiders sold 487,659 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 487,659 shares. During the past 18 months, 5,623,539 shares of Metacrine Inc (MTCR) were sold and 2,510,570 shares were bought by its insiders, resulting in a net sale of 3,112,969 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 225,000 shares made by Samarth Kulkarni ,

In summary, during the past 3 months, insiders sold 50,000 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 225,000 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,000 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Genocea Biosciences Inc (GNCAQ). Other recent insider transactions involving Genocea Biosciences Inc (GNCAQ) include a net sale of 121,168 shares made by William D Clark , a net sale of 25,370 shares made by Diantha Duvall , and a net sale of 17,737 shares made by Jessica Baker Flechtner .

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 93,584,178 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 93,584,178 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 35,206 shares made by Ralph Brandenberger , a net sale of 23,622 shares made by Nadir Mahmood , and a net sale of 33,691 shares made by Paul J Hastings .

In summary, during the past 3 months, insiders sold 7,697 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 7,697 shares. During the past 18 months, 99,912 shares of Nkarta Inc (NKTX) were sold and 3,533,333 shares were bought by its insiders, resulting in a net purchase of 3,433,421 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 80,996 shares made by Adrian Rawcliffe , a net sale of 28,496 shares made by John Lunger , and a net sale of 27,132 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 93,715 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 93,715 shares. During the past 18 months, 190,599 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 39,000 shares were bought by its insiders, resulting in a net sale of 151,599 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Akouos Inc (AKUS). Other recent insider transactions involving Akouos Inc (AKUS) include a net purchase of 29,992,668 shares made by Kearny Acquisition Corp ,

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 29,992,668 shares were bought by its insiders, resulting in a net purchase of 29,992,668 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Oyster Point Pharma Inc (OYST). Other recent insider transactions involving Oyster Point Pharma Inc (OYST) include a net sale of 550,000 shares made by Versant Venture Capital Vi, L.p. , a net sale of 550,000 shares made by Ozawa Clare , and a net sale of 550,000 shares made by Link William J Phd .

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,650,000 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,650,000 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made 1 insider transaction in Trevi Therapeutics Inc (TRVI) with a net purchase of 3,580,526. Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 1,000,000 shares made by Tpg Gp A, Llc , a net sale of 9,366 shares made by Lisa Delfini , and a net purchase of 3,580,526 shares made by Peter W. Sonsini .

In summary, during the past 3 months, insiders sold 9,366 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 9,366 shares. During the past 18 months, 1,009,366 shares of Trevi Therapeutics Inc (TRVI) were sold and 30,326,838 shares were bought by its insiders, resulting in a net purchase of 29,317,472 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 1,641,993 shares made by Biotech Growth N V , and a net purchase of 81,363 shares made by Fang Ni .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 1,723,356 shares were bought by its insiders, resulting in a net purchase of 1,723,356 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net purchase of 100,000 shares made by Denis Drygin , and a net purchase of 100,000 shares made by Joseph P Hagan .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regulus Therapeutics Inc (RGLS) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 20,000 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net purchase of 3,328 shares made by Christopher Peetz , a net sale of 124 shares made by Ian Clements , and a net sale of 300,000 shares made by Niall O'donnell .

In summary, during the past 3 months, insiders sold 0 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 348,777 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 8,450 shares were bought by its insiders, resulting in a net sale of 340,327 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 77,665 shares made by Paula Ragan , a net sale of 80,221 shares made by Adam S. Mostafa , and a net sale of 22,540 shares made by Mary Dibiase .

In summary, during the past 3 months, insiders sold 191,868 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 191,868 shares. During the past 18 months, 198,160 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 198,160 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Nevro Corp (NVRO). Other recent insider transactions involving Nevro Corp (NVRO) include a net purchase of 4,250 shares made by Kashif Rashid , a net purchase of 20,000 shares made by Elizabeth H Weatherman , and a net purchase of 3,200 shares made by D Keith Grossman .

In summary, during the past 3 months, insiders sold 0 shares of Nevro Corp (NVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nevro Corp (NVRO) were sold and 29,850 shares were bought by its insiders, resulting in a net purchase of 29,850 shares.

Nevro Corp (NVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Savara Inc (SVRA). Other recent insider transactions involving Savara Inc (SVRA) include a net purchase of 964,000 shares made by David A Ramsay , a net purchase of 38,650 shares made by Matthew Pauls , and a net purchase of 25,000 shares made by Badrul A. Chowdhury .

In summary, during the past 3 months, insiders sold 0 shares of Savara Inc (SVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Savara Inc (SVRA) were sold and 1,035,150 shares were bought by its insiders, resulting in a net purchase of 1,035,150 shares.

Savara Inc (SVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in CVRx Inc (CVRX). Other recent insider transactions involving CVRx Inc (CVRX) include a net purchase of 187,220 shares made by Kirk G. Nielsen , a net purchase of 1,775 shares made by Mudit K. Jain , and a net sale of 4,600 shares made by Paul Verrastro .

In summary, during the past 3 months, insiders sold 0 shares of CVRx Inc (CVRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,600 shares of CVRx Inc (CVRX) were sold and 188,995 shares were bought by its insiders, resulting in a net purchase of 184,395 shares.

CVRx Inc (CVRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Minerva Surgical Inc (UTRS). Other recent insider transactions involving Minerva Surgical Inc (UTRS) include a net purchase of 25,737,927 shares made by New Enterprise Associates 13 Lp , a net purchase of 580,000 shares made by Novo Holdings A/s , and a net purchase of 25,000 shares made by David M Clapper .

In summary, during the past 3 months, insiders sold 0 shares of Minerva Surgical Inc (UTRS) in total and bought 24,437,927 shares, with a net purchase of 24,437,927 shares. During the past 18 months, 0 shares of Minerva Surgical Inc (UTRS) were sold and 26,342,927 shares were bought by its insiders, resulting in a net purchase of 26,342,927 shares.

Minerva Surgical Inc (UTRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Bright Health Group Inc (BHG). Other recent insider transactions involving Bright Health Group Inc (BHG) include a net purchase of 1,185,000 shares made by Manuel Kadre , a net purchase of 400,000 shares made by Jeffrey R Immelt , and a net sale of 394,896 shares made by Mikan George Lawrence Iii .

In summary, during the past 3 months, insiders sold 574,032 shares of Bright Health Group Inc (BHG) in total and bought 0 shares, with a net sale of 574,032 shares. During the past 18 months, 574,032 shares of Bright Health Group Inc (BHG) were sold and 1,585,000 shares were bought by its insiders, resulting in a net purchase of 1,010,968 shares.

Bright Health Group Inc (BHG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ali Behbahani made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 23,221 shares made by Christopher Heery , a net purchase of 1,895,833 shares made by New Enterprise Associates 15, L.p. , and a net sale of 569 shares made by Scott D Sandell .

In summary, during the past 3 months, insiders sold 42,163 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 42,163 shares. During the past 18 months, 57,218 shares of Arcellx Inc (ACLX) were sold and 4,395,833 shares were bought by its insiders, resulting in a net purchase of 4,338,615 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.